These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 26390158)

  • 21. Pancreatic cancer: Are "liquid biopsies" ready for prime-time?
    Lewis AR; Valle JW; McNamara MG
    World J Gastroenterol; 2016 Aug; 22(32):7175-85. PubMed ID: 27621566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular detection of pancreatic neoplasia: Current status and future promise.
    Majumder S; Chari ST; Ahlquist DA
    World J Gastroenterol; 2015 Oct; 21(40):11387-95. PubMed ID: 26526068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive and prognostic value of circulating tumor cell detection in lung cancer: a clinician's perspective.
    Tognela A; Spring KJ; Becker T; Caixeiro NJ; Bray VJ; Yip PY; Chua W; Lim SH; de Souza P
    Crit Rev Oncol Hematol; 2015 Feb; 93(2):90-102. PubMed ID: 25459665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular vesicles for personalized therapy decision support in advanced metastatic cancers and its potential impact for prostate cancer.
    Soekmadji C; Corcoran NM; Oleinikova I; Jovanovic L; ; Ramm GA; Nelson CC; Jenster G; Russell PJ
    Prostate; 2017 Oct; 77(14):1416-1423. PubMed ID: 28856701
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The emerging role of liquid biopsy in diagnosis, prognosis and treatment monitoring of pancreatic cancer.
    Rofi E; Vivaldi C; Del Re M; Arrigoni E; Crucitta S; Funel N; Fogli S; Vasile E; Musettini G; Fornaro L; Falcone A; Danesi R
    Pharmacogenomics; 2019 Jan; 20(1):49-68. PubMed ID: 30520336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating tumor cells in pancreatic cancer patients: efficacy in diagnosis and value in prognosis.
    Xie ZB; Yao L; Jin C; Fu DL
    Discov Med; 2016 Sep; 22(120):121-128. PubMed ID: 27755967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma.
    Gall TMH; Belete S; Khanderia E; Frampton AE; Jiao LR
    Am J Pathol; 2019 Jan; 189(1):71-81. PubMed ID: 30558725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next-generation Sequencing (NGS) Analysis on Single Circulating Tumor Cells (CTCs) with No Need of Whole-genome Amplification (WGA).
    Palmirotta R; Lovero D; Silvestris E; Felici C; Quaresmini D; Cafforio P; Silvestris F
    Cancer Genomics Proteomics; 2017; 14(3):173-179. PubMed ID: 28446532
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment and Application of Prostate Cancer Circulating Tumor Cells in the Era of Precision Medicine.
    Suh YS; Joung JY; Kim SH; Seo HK; Chung J; Lee KH
    Biomed Res Int; 2017; 2017():7206307. PubMed ID: 29230413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result.
    Kurihara T; Itoi T; Sofuni A; Itokawa F; Tsuchiya T; Tsuji S; Ishii K; Ikeuchi N; Tsuchida A; Kasuya K; Kawai T; Sakai Y; Moriyasu F
    J Hepatobiliary Pancreat Surg; 2008; 15(2):189-95. PubMed ID: 18392713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating tumor cells: a multifunctional biomarker.
    Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
    Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ligand-targeted polymerase chain reaction for the detection of folate receptor-positive circulating tumour cells as a potential diagnostic biomarker for pancreatic cancer.
    Cheng H; He W; Yang J; Ye Q; Cheng L; Pan Y; Mao L; Chu X; Lu C; Li G; Qiu Y; He J
    Cell Prolif; 2020 Sep; 53(9):e12880. PubMed ID: 32707596
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES; Strati A; Markou A
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer.
    Earl J; Garcia-Nieto S; Martinez-Avila JC; Montans J; Sanjuanbenito A; Rodríguez-Garrote M; Lisa E; Mendía E; Lobo E; Malats N; Carrato A; Guillen-Ponce C
    BMC Cancer; 2015 Oct; 15():797. PubMed ID: 26498594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What's new in the diagnosis of pancreatic cancer: a patent review (2011-present).
    Boulaiz H; Ramos MC; Griñán-Lisón C; García-Rubiño ME; Vicente F; Marchal JA
    Expert Opin Ther Pat; 2017 Dec; 27(12):1319-1328. PubMed ID: 28929814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chances and risks of blood-based molecular pathological analysis of circulating tumor cells (CTC) and cell-free DNA (cfDNA) in personalized cancer therapy: positional paper from the study group on liquid biopsy of the working group for molecular pathology in the German Society of Pathology (DGP)].
    Dahl E; Jung A; Fassunke J; Hummel M; Penzel R; Dietmaier W; Laßmann S
    Pathologe; 2015 Feb; 36(1):92-7. PubMed ID: 25533324
    [No Abstract]   [Full Text] [Related]  

  • 37. Circulating tumor cells in the diagnosis and management of pancreatic cancer.
    Cen P; Ni X; Yang J; Graham DY; Li M
    Biochim Biophys Acta; 2012 Dec; 1826(2):350-6. PubMed ID: 22683404
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids.
    Imamura T; Komatsu S; Ichikawa D; Kawaguchi T; Miyamae M; Okajima W; Ohashi T; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
    World J Gastroenterol; 2016 Jul; 22(25):5627-41. PubMed ID: 27433079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of circulating tumor cells during follow-up of patients with early breast cancer: Clinical utility for monitoring of therapy efficacy.
    Mikulová V; Cabiňaková M; Janatková I; Mestek O; Zima T; Tesařová P
    Scand J Clin Lab Invest; 2014 Mar; 74(2):132-42. PubMed ID: 24350991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Using CTCs for pharmacogenomic analysis.
    Hart CD; Galardi F; Pestrin M; De Luca F; Risi E; Di Leo A
    Pharmacol Res; 2016 Apr; 106():92-100. PubMed ID: 26921662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.